Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07044271
PHASE1

A Study of Multiple Olomorasib (LY3537982) Capsules in Healthy Participants

Sponsor: Eli Lilly and Company

View on ClinicalTrials.gov

Summary

The main purpose of this study is to measure how much olomorasib gets into the bloodstream and how long it takes the body to get rid of it. Healthy participants will take olomorasib by mouth. The study will last about 7 weeks and will include 10 back-to-back overnight stays in the research center.

Official title: An Open-Label, Randomized, 3-Way Crossover Study Comparing the Pharmacokinetics of Multiple Olomorasib (LY3537982) Capsules

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

120

Start Date

2025-07-11

Completion Date

2025-11

Last Updated

2025-10-20

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Olomorasib

Single dose

Locations (2)

ICON Early Phase Services

San Antonio, Texas, United States

ICON

Salt Lake City, Utah, United States